When analyzing the drug delivery product pipeline, three key technologies stand out. Check out the latest market research.

Hi and welcome to our monthly video series called what’s trending online. At the HCP site there are six articles that readers ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

According to results published October 20, 2025, in the New England Journal of Medicine, a newly developed, tiny, and wireless retinal implant device is helping restore vision in individuals with ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

A significant proportion of repeated pregnancy failures can be attributed to chromosomal abnormalities—either inherited from one of the parents or arising spontaneously in the embryo.

Abstract: Genome-wide screening using microarrays of DNA will be of great use in the early diagnosis of diseases such as cancer and HIV. It also makes use of gene discovery, pharmacogenomics, ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including ...

Family launches plea to fund research into rare CRELD1 syndrome.